APAC Taxane Market - Industry Trends and Forecast to 2029
Description
APAC Taxane Market - Industry Trends and Forecast to 2029
Asia-Pacific taxane market is projected to register a substantial CAGR of 8.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Market Segmentation
Asia-Pacific Taxane Market, By Type (Paclitaxel, Docetaxel, Cabazitaxel), Drug Type (Generics, Branded), Formulation (Liposomes, Nanoparticles, Polymeric Micelles, Others), Age Group (Adults, Geriatric), Application (Breast Cancer, Non-Small Lung Cancer, Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) Distribution Channel (Retail Sales, Direct Tender), Country (China, Japan, India, South Korea, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific taxane market are:
• The rise in incidence of cancer
• The funding by the government and investment in research and development
Market Segmentation
Asia-Pacific taxane market is categorized into seven notable segment which is type, drug type, formulation, age group, application, end user and distribution channel.
• On the basis of type, the Asia-Pacific taxane market is segmented into paclitaxel, docetaxel and cabazitaxel.
• On the basis of application, the Asia-Pacific taxane market is segmented into ovarian cancer, breast cancer, prostate cancer, non-small cell lung cancer and other
• On the basis of drug type, the Asia-Pacific taxane market is segmented into branded and generics
• On the basis of formulation, the Asia-Pacific taxane market is segmented into liposomes, nanoparticles, polymeric micelles and others
• On the basis of age group, the Asia-Pacific taxane market is segmented into adults and geriatric
• On the basis of end user, the Asia-Pacific taxane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others
• On the basis of distribution channel, the Asia-Pacific taxane market is segmented into direct tender, retail sales
Market Players
The key market players for Asia-Pacific taxane market are listed below:
• Viatris Inc.
• Sandoz International GmbH (A Novartis Division)
• sanofi-aventis U.S. LLC
• Hikma Pharmaceuticals PLC
• Pfizer Inc.
• Dr. Reddy’s Laboratories Ltd.
• Taxane Healthcare
• Bristol-Myers Squibb Company
• Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA)
• SAMYANG HOLDINGS CORPORATION.
• Luye Pharma Group
• Elevar Therapeutics
• Huiang Pharmaceutical Co Ltd.
• Shenzhen Main Luck Pharmaceuticals Inc.
• Accord Healthcare
• Torrent Pharmaceuticals Ltd.
• Panacea Biotec
• RPG Life Sciences Limited.
• Aureate Healthcare
• Samarth Life Sciences Pvt. Ltd.
• Cipla Inc.
• Hetero Healthcare Limited.
• Ingenus Pharmaceuticals, LLC
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Asia-Pacific taxane market is projected to register a substantial CAGR of 8.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Market Segmentation
Asia-Pacific Taxane Market, By Type (Paclitaxel, Docetaxel, Cabazitaxel), Drug Type (Generics, Branded), Formulation (Liposomes, Nanoparticles, Polymeric Micelles, Others), Age Group (Adults, Geriatric), Application (Breast Cancer, Non-Small Lung Cancer, Pancreatic Cancer, Ovarian Cancer, Prostate Cancer, Others), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others) Distribution Channel (Retail Sales, Direct Tender), Country (China, Japan, India, South Korea, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific taxane market are:
• The rise in incidence of cancer
• The funding by the government and investment in research and development
Market Segmentation
Asia-Pacific taxane market is categorized into seven notable segment which is type, drug type, formulation, age group, application, end user and distribution channel.
• On the basis of type, the Asia-Pacific taxane market is segmented into paclitaxel, docetaxel and cabazitaxel.
• On the basis of application, the Asia-Pacific taxane market is segmented into ovarian cancer, breast cancer, prostate cancer, non-small cell lung cancer and other
• On the basis of drug type, the Asia-Pacific taxane market is segmented into branded and generics
• On the basis of formulation, the Asia-Pacific taxane market is segmented into liposomes, nanoparticles, polymeric micelles and others
• On the basis of age group, the Asia-Pacific taxane market is segmented into adults and geriatric
• On the basis of end user, the Asia-Pacific taxane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others
• On the basis of distribution channel, the Asia-Pacific taxane market is segmented into direct tender, retail sales
Market Players
The key market players for Asia-Pacific taxane market are listed below:
• Viatris Inc.
• Sandoz International GmbH (A Novartis Division)
• sanofi-aventis U.S. LLC
• Hikma Pharmaceuticals PLC
• Pfizer Inc.
• Dr. Reddy’s Laboratories Ltd.
• Taxane Healthcare
• Bristol-Myers Squibb Company
• Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA)
• SAMYANG HOLDINGS CORPORATION.
• Luye Pharma Group
• Elevar Therapeutics
• Huiang Pharmaceutical Co Ltd.
• Shenzhen Main Luck Pharmaceuticals Inc.
• Accord Healthcare
• Torrent Pharmaceuticals Ltd.
• Panacea Biotec
• RPG Life Sciences Limited.
• Aureate Healthcare
• Samarth Life Sciences Pvt. Ltd.
• Cipla Inc.
• Hetero Healthcare Limited.
• Ingenus Pharmaceuticals, LLC
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Table of Contents
235 Pages
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Asia Pacific Taxane Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Dbmr Tripod Data Validation Model
- 2.5 Primary Interviews With Key Opinion Leaders
- 2.6 Multivariate Modelling
- 2.7 Market Application Coverage Grid
- 2.8 Type Lifeline Curve
- 2.9 Dbmr Market Position Grid
- 2.10 Vendor Share Analysis
- 2.11 Secondary Sources
- 2.12 Assumptions
- 3 Executive Summary
- 4 Premium Insight
- 4.1 Pestel_analysis
- 4.2 Porter's Five Forces Model
- 5 Epidemiology
- 6 Industrial Insights
- 6.1 Conclusion
- 7 Asia Pacific Taxane Market: Regulations
- 8 Market Overview
- 8.1 Drivers
- 8.1.1 The Rise In Incidence Of Cancer
- 8.1.2 The Funding By The Government And Investment In Research And Development
- 8.1.3 Rise In Pipeline Or Clinical Trials Of Taxane Treatments
- 8.1.4 Use Of Reimbursement For Taxane
- 8.2 Restraints
- 8.2.1 Side Effects Of Drugs Incurred With The Taxane Drugs
- 8.2.2 Ethical Issues Related To The Use Of Taxane Treatment
- 8.2.3 Rise In Product Recalls
- 8.3 Opportunities
- 8.3.1 Strategic Initiative By Market Players
- 8.3.2 Rise In Healthcare Expenditure
- 8.4 Challenges
- 8.4.1 The Lack Of Skilled Professionals Required For Taxane Drug Treatment
- 8.4.2 Stringent Government Regulations On Taxane Drug Treatment
- 9 Asia Pacific Taxane Market, By Type
- 9.1 Overview
- 9.2 Paclitaxel
- 9.2.1 By Type
- 9.2.1.1 Semi-synthetic
- 9.2.1.2 Natural
- 9.2.2 By Strength
- 9.2.2.1 100mg
- 9.2.2.2 200mg
- 9.2.2.3 250mg
- 9.2.2.4 30mg
- 9.2.2.5 260mg
- 9.2.2.6 300mg
- 9.3 Docetaxel
- 9.3.1 120mg
- 9.3.2 80mg
- 9.3.3 20mg
- 9.3.4 40mg
- 9.3.5 60mg
- 9.4 Cabazitaxel
- 9.4.1 60mg
- 10 Asia Pacific Taxane Market, By Application
- 10.1 Overview
- 10.2 Breast Cancer
- 10.3 Non-small Cell Lung Cancer
- 10.4 Pancreatic Cancer
- 10.5 Ovarian Cancer
- 10.6 Prostate Cancer
- 10.7 Others
- 11 Asia Pacific Taxane Market, By Drug Type
- 11.1 Overview
- 11.2 Generics
- 11.3 Branded
- 12 Asia Pacific Taxane Market, By Formulation
- 12.1 Overview
- 12.2 Liposomes
- 12.3 Nanoparticles
- 12.4 Polymeric Micelles
- 12.5 Others
- 13 Asia Pacific Taxane Market, By Age Group
- 13.1 Overview
- 13.2 Adult
- 13.2.1 Female
- 13.2.2 Male
- 13.3 Geriatric
- 13.3.1 Female
- 13.3.2 Male
- 14 Asia Pacific Taxane Market, By End User
- 14.1 Overview
- 14.2 Hospitals
- 14.3 Ambulatory Surgical Centers
- 14.4 Specialty Clinics
- 14.5 Others
- 15 Asia Pacific Taxane Market, By Distribution Channel
- 15.1 Overview
- 15.2 Retail Sales
- 15.2.1 Hospital Pharmacy
- 15.2.2 Retail Pharmacy
- 15.2.3 Online Pharmacy
- 15.3 Direct Tender
- 16 Asia Pacific Taxane Market, By Region
- 16.1 Asia-pacific
- 16.1.1 China
- 16.1.2 Japan
- 16.1.3 India
- 16.1.4 South Korea
- 16.1.5 Australia
- 16.1.6 Indonesia
- 16.1.7 Thailand
- 16.1.8 Philippines
- 16.1.9 Vietnam
- 16.1.10 Singapore
- 16.1.11 Malaysia
- 16.1.12 Rest Of Asia-pacific
- 17 Asia Pacific Taxane Market: Company Landscape
- 17.1 Company Share Analysis: Asia Pacific
- 18 Swot Analysis
- 19 Company Profile
- 19.1 Bristol-myers Squibb Company
- 19.1.1 Company Snapshot
- 19.1.2 Revenue Analysis
- 19.1.3 Company Share Analysis
- 19.1.4 Product Portfolio
- 19.1.5 Recent Developments
- 19.2 Sanofi-aventis U.S. Llc
- 19.2.1 Company Snapshot
- 19.2.2 Revenue Analysis
- 19.2.3 Company Share Analysis
- 19.2.4 Product Portfolio
- 19.2.5 Recent Developments
- 19.3 Viatris Inc.
- 19.3.1 Company Snapshot
- 19.3.2 Revenue Analysis
- 19.3.3 Company Share Analysis
- 19.3.4 Product Portfolio
- 19.3.5 Recent Development
- 19.4 Sandoz International Gmbh (A Novartis Division)
- 19.4.1 Company Snapshot
- 19.4.2 Revenue Analysis
- 19.4.3 Company Share Analysis
- 19.4.4 Product Portfolio
- 19.4.5 Recent Developments
- 19.5 Fresenius Kabi Ag (Subsidiary Of Fresenius Se & Co. Kgaa )
- 19.5.1 Company Snapshot
- 19.5.2 Revenue Analysis
- 19.5.3 Company Share Analysis
- 19.5.4 Product Portfolio
- 19.5.5 Recent Developments
- 19.6 Hikma Pharmaceuticals Plc
- 19.6.1 Company Snapshot
- 19.6.2 Revenue Analysis
- 19.6.3 Product Portfolio
- 19.6.4 Recent Developments
- 19.7 Accord Healthcare
- 19.7.1 Company Snapshot
- 19.7.2 Product Portfolio
- 19.7.3 Recent Developments
- 19.8 Aqvida Gmbh
- 19.8.1 Company Snapshot
- 19.8.2 Product Portfolio
- 19.8.3 Recent Developments
- 19.9 Aureate Healthcare
- 19.9.1 Company Snapshot
- 19.9.2 Product Portfolio
- 19.9.3 Recent Developments
- 19.10 Cipla Inc.
- 19.10.1 Company Snapshot
- 19.10.2 Revenue Analysis
- 19.10.3 Product Portfolio
- 19.10.4 Recent Developments
- 19.11 Dr. Reddy’s Laboratories Ltd.
- 19.11.1 Company Snapshot
- 19.11.2 Revenue Analysis
- 19.11.3 Product Portfolio
- 19.11.4 Recent Developments
- 19.12 Elevar Therapeutics
- 19.12.1 Company Snapshot
- 19.12.2 Product Portfolio
- 19.12.3 Recent Developments
- 19.13 Hetero Healthcare Limited.
- 19.13.1 Company Snapshot
- 19.13.2 Product Portfolio
- 19.13.3 Recent Developments
- 19.14 Huiang Pharmaceutical Co Ltd
- 19.14.1 Company Snapshot
- 19.14.2 Product Portfolio
- 19.14.3 Recent Developments
- 19.15 Ingenus Pharmaceuticals, Llc
- 19.15.1 Company Snapshot
- 19.15.2 Product Portfolio
- 19.15.3 Recent Developments
- 19.16 Luye Pharma Group
- 19.16.1 Company Snapshot
- 19.16.2 Revenue Analysis
- 19.16.3 Product Portfolio
- 19.16.4 Recent Developments
- 19.17 Panacea Biotec
- 19.17.1 Company Snapshot
- 19.17.2 Revenue Analysis
- 19.17.3 Product Portfolio
- 19.17.4 Recent Developments
- 19.18 Pfizer Inc.
- 19.18.1 Company Snapshot
- 19.18.2 Revenue Analysis
- 19.18.3 Product Portfolio
- 19.18.4 Recent Developments
- 19.19 Rpg Life Sciences Limited
- 19.19.1 Company Snapshot
- 19.19.2 Revenue Analysis
- 19.19.3 Product Portfolio
- 19.19.4 Recent Developments
- 19.20 Samarth Life Sciences Pvt. Ltd.
- 19.20.1 Company Snapshot
- 19.20.2 Product Portfolio
- 19.20.3 Recent Developments
- 19.21 Samyang Holdings Corporation.
- 19.21.1 Company Snapshot
- 19.21.2 Revenue Analysis
- 19.21.3 Product Portfolio
- 19.21.4 Recent Developments
- 19.22 Shenzhen Main Luck Phar Maceuticals Inc.
- 19.22.1 Company Snapshot
- 19.22.2 Product Portfolio
- 19.22.3 Recent Developments
- 19.23 Torrent Pharmaceuticals Ltd
- 19.23.1 Company Snapshot
- 19.23.2 Revenue Analysis
- 19.23.3 Product Portfolio
- 19.23.4 Recent Developments
- 19.24 Taxane Healthcare
- 19.24.1 Company Snapshot
- 19.24.2 Product Portfolio
- 19.24.3 Recent Developments
- 20 Questionnaire
- 21 Related Reports
- List Of Tables
- Table 1 Asia Pacific Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 2 Asia Pacific Paclitaxel In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 3 Asia Pacific Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 4 Asia Pacific Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 5 Asia Pacific Docetaxel In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 6 Asia Pacific Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 7 Asia Pacific Cabazitaxel In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 8 Asia Pacific Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 9 Asia Pacific Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 10 Asia Pacific Breast Cancer In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 11 Asia Pacific Non-small Lung Cancer In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 12 Asia Pacific Pancreatic Cancer In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 13 Asia Pacific Ovarian Cancer In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 14 Asia Pacific Prostate Cancer In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 15 Asia Pacific Others In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 16 Asia Pacific Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 17 Asia Pacific Generics In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 18 Asia Pacific Branded In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 19 Asia Pacific Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 20 Asia Pacific Liposomes In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 21 Asia Pacific Nanoparticles In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 22 Asia Pacific Polymeric Micelles In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 23 Asia Pacific Others In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 24 Asia Pacific Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 25 Asia Pacific Adult In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 26 Asia Pacific Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 27 Asia Pacific Geriatric In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 28 Asia Pacific Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 29 Asia Pacific Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 30 Asia Pacific Hospitals In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 31 Asia Pacific Ambulatory Surgical Centers In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 32 Asia Pacific Specialty Clinics In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 33 Asia Pacific Others In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 34 Asia Pacific Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 35 Asia Pacific Retail Sales In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 36 Asia Pacific Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 37 Asia Pacific Direct Tender In Taxane Market, By Region, 2020-2029 (Usd Million)
- Table 38 Asia-pacific Taxane Market, By Country, 2020-2029 (Usd Million)
- Table 39 Asia-pacific Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 40 Asia-pacific Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 41 Asia-pacific Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 42 Asia-pacific Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 43 Asia-pacific Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 44 Asia-pacific Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 45 Asia-pacific Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 46 Asia-pacific Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 47 Asia-pacific Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 48 Asia-pacific Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 49 Asia-pacific Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 50 Asia-pacific Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 51 Asia-pacific Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 52 Asia-pacific Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 53 China Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 54 China Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 55 China Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 56 China Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 57 China Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 58 China Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 59 China Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 60 China Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 61 China Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 62 China Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 63 China Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 64 China Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 65 China Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 66 China Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 67 Japan Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 68 Japan Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 69 Japan Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 70 Japan Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 71 Japan Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 72 Japan Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 73 Japan Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 74 Japan Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 75 Japan Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 76 Japan Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 77 Japan Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 78 Japan Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 79 Japan Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 80 Japan Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 81 India Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 82 India Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 83 India Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 84 India Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 85 India Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 86 India Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 87 India Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 88 India Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 89 India Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 90 India Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 91 India Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 92 India Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 93 India Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 94 India Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 95 South Korea Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 96 South Korea Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 97 South Korea Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 98 South Korea Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 99 South Korea Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 100 South Korea Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 101 South Korea Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 102 South Korea Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 103 South Korea Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 104 South Korea Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 105 South Korea Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 106 South Korea Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 107 South Korea Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 108 South Korea Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 109 Australia Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 110 Australia Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 111 Australia Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 112 Australia Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 113 Australia Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 114 Australia Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 115 Australia Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 116 Australia Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 117 Australia Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 118 Australia Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 119 Australia Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 120 Australia Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 121 Australia Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 122 Australia Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 123 Indonesia Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 124 Indonesia Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 125 Indonesia Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 126 Indonesia Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 127 Indonesia Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 128 Indonesia Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 129 Indonesia Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 130 Indonesia Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 131 Indonesia Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 132 Indonesia Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 133 Indonesia Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 134 Indonesia Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 135 Indonesia Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 136 Indonesia Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 137 Thailand Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 138 Thailand Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 139 Thailand Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 140 Thailand Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 141 Thailand Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 142 Thailand Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 143 Thailand Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 144 Thailand Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 145 Thailand Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 146 Thailand Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 147 Thailand Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 148 Thailand Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 149 Thailand Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 150 Thailand Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 151 Philippines Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 152 Philippines Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 153 Philippines Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 154 Philippines Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 155 Philippines Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 156 Philippines Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 157 Philippines Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 158 Philippines Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 159 Philippines Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 160 Philippines Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 161 Philippines Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 162 Philippines Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 163 Philippines Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 164 Philippines Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 165 Vietnam Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 166 Vietnam Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 167 Vietnam Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 168 Vietnam Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 169 Vietnam Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 170 Vietnam Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 171 Vietnam Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 172 Vietnam Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 173 Vietnam Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 174 Vietnam Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 175 Vietnam Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 176 Vietnam Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 177 Vietnam Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 178 Vietnam Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 179 Singapore Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 180 Singapore Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 181 Singapore Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 182 Singapore Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 183 Singapore Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 184 Singapore Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 185 Singapore Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 186 Singapore Cabazitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 187 Singapore Taxane Market, By Age Group, 2020-2029 (Usd Million)
- Table 188 Singapore Adult In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 189 Singapore Geriatric In Taxane Market, By Gender, 2020-2029 (Usd Million)
- Table 190 Singapore Taxane Market, By End User, 2020-2029 (Usd Million)
- Table 191 Singapore Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 192 Singapore Retail Sales In Taxane Market, By Distribution Channel, 2020-2029 (Usd Million)
- Table 193 Malaysia Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 194 Malaysia Paclitaxel In Taxane Market, By Type, 2020-2029 (Usd Million)
- Table 195 Malaysia Taxane Market, By Application, 2020-2029 (Usd Million)
- Table 196 Malaysia Taxane Market, By Drug Type, 2020-2029 (Usd Million)
- Table 197 Malaysia Taxane Market, By Formulation, 2020-2029 (Usd Million)
- Table 198 Malaysia Paclitaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- Table 199 Malaysia Docetaxel In Taxane Market, By Strength, 2020-2029 (Usd Million)
- List Of Figures
- Figure 1 Asia Pacific Taxane Market: Segmentation
- Figure 2 Asia Pacific Taxane Market: Data Triangulation
- Figure 3 Asia Pacific Taxane Market: Droc Analysis
- Figure 4 Asia Pacific Taxane Market: Regional Vs Country Market Analysis
- Figure 5 Asia Pacific Taxane Market: Company Research Analysis
- Figure 6 Asia Pacific Taxane Market: Interview Demographics
- Figure 7 Asia Pacific Taxane Market: Market Application Coverage Grid
- Figure 8 Asia Pacific Taxane Market: Dbmr Market Position Grid
- Figure 9 Asia Pacific Taxane Market: Vendor Share Analysis
- Figure 10 Asia Pacific Taxane Market: Segmentation
- Figure 11 North America Is Anticipated To Dominate The Asia Pacific Taxane Market And Asia-pacific Is Estimated To Be Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029
- Figure 12 Increasing Investment For Healthcare Infrastructure Is Expected To Drive The Asia Pacific Taxane Market In The Forecast Period Of 2022 To 2029
- Figure 13 The Type Segment Is Expected To Account For The Largest Share Of The Asia Pacific Taxane Market In 2022 & 2029
- Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The Asia Pacific Taxane Market
- Figure 15 Incidence Of Breast Cancer In 2020
- Figure 16 Asia Pacific Taxane Market: By Type, 2021
- Figure 17 Asia Pacific Taxane Market: By Type, 2022-2029 (Usd Million)
- Figure 18 Asia Pacific Taxane Market: By Type, Cagr (2022-2029)
- Figure 19 Asia Pacific Taxane Market: By Type, Lifeline Curve
- Figure 20 Asia Pacific Taxane Market: By Application, 2021
- Figure 21 Asia Pacific Taxane Market: By Application, 2022-2029 (Usd Million)
- Figure 22 Asia Pacific Taxane Market: By Application, Cagr (2022-2029)
- Figure 23 Asia Pacific Taxane Market: By Application, Lifeline Curve
- Figure 24 Asia Pacific Taxane Market: By Drug Type, 2021
- Figure 25 Asia Pacific Taxane Market: By Drug Type, 2022-2029 (Usd Million)
- Figure 26 Asia Pacific Taxane Market: By Drug Type, Cagr (2022-2029)
- Figure 27 Asia Pacific Taxane Market: By Drug Type, Lifeline Curve
- Figure 28 Asia Pacific Taxane Market: By Formulation, 2021
- Figure 29 Asia Pacific Taxane Market: By Formulation, 2022-2029 (Usd Million)
- Figure 30 Asia Pacific Taxane Market: By Formulation, Cagr (2022-2029)
- Figure 31 Asia Pacific Taxane Market: By Formulation, Lifeline Curve
- Figure 32 Asia Pacific Taxane Market: By Age Group, 2021
- Figure 33 Asia Pacific Taxane Market: By Age Group, 2022-2029 (Usd Million)
- Figure 34 Asia Pacific Taxane Market: By Age Group, Cagr (2022-2029)
- Figure 35 Asia Pacific Taxane Market: By Age Group, Lifeline Curve
- Figure 36 Asia Pacific Taxane Market: By End User, 2021
- Figure 37 Asia Pacific Taxane Market: By End User, 2022-2029 (Usd Million)
- Figure 38 Asia Pacific Taxane Market: By End User, Cagr (2022-2029)
- Figure 39 Asia Pacific Taxane Market: By End User, Lifeline Curve
- Figure 40 Asia Pacific Taxane Market: By Distribution Channel, 2021
- Figure 41 Asia Pacific Taxane Market: By Distribution Channel, 2022-2029 (Usd Million)
- Figure 42 Asia Pacific Taxane Market: By Distribution Channel, Cagr (2022-2029)
- Figure 43 Asia Pacific Taxane Market: By Distribution Channel, Lifeline Curve
- Figure 44 Asia-pacific Taxane Market: Snapshot (2021)
- Figure 45 Asia-pacific Taxane Market: By Country (2021)
- Figure 46 Asia-pacific Taxane Market: By Country (2022 & 2029)
- Figure 47 Asia-pacific Taxane Market: By Country (2021 & 2029)
- Figure 48 Asia-pacific Taxane Market: By Type (2022-2029)
- Figure 49 Asia Pacific Taxane Market: Company Share 2021 (%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
